Overview

Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2018-11-30
Target enrollment:
Participant gender:
Summary
Study to assess the long-term safety and effectiveness of Spiolto in Japanese patients with Chronic Obstructive Pulmonary Disease (COPD) in real-world setting
Details
Lead Sponsor:
Boehringer Ingelheim